CBX3 and neoplasm: The fact that more CD8+ T cells with effector characteristics are recovered from tumors of Cbx3/HP1γ-insufficient mice suggests that Cbx3/HP1γ insufficiency can reinvigorate the effector capacity of CD8+ T cells to control tumor growth.